News

LISAvienna News

Business Treff at AME International

In January 2012 the Vienna-based company AME International GmbH opened their doors to the public interested in life...

Two Pi awarded First Prize for Innovations in User-centered Hearing Aid Fitting

The Viennese company Two Pi has captured first prize in the “Life Sciences 2011” event organized by the Technology...

International Contacts Boost Business

Networking on an international level is essential for successful companies. With this in mind many Austrian companies...

AVIR Green Hills reaches important Milestone

 

AVIR Green Hills Biotechnology AG is testing the trivalent influenza vaccine deltaFLU in a phase I/II study at the...

F-Star and Merck Serono to Collaborate in the Discovery and Development of Novel Targeted Biologics

 

Vienna, Austria, (September 7th 2011) -- F-Star GmbH today announced that a research, license and commercialisation...

Apeiron acquires rights for Phase III immunotherapy against high-risk neuroblastoma from CCRI and SIOPEN

APEIRON Biologics AG (Apeiron) today announced the signing of agreements with the Children’s Cancer Research Institute,...

Best of Biotech 2010: The Winners

In October 2010, the international life science business plan competition “Best of Biotech” (BOB) – funded by the...

Best of Biotech 2010: The Winners

In October 2010, the international life science business plan competition “Best of Biotech” (BOB) – funded by the...

Themis Bioscience completes Series A Financing round – EUR 5 Million to advance promising vaccine candidates

Vienna, 18. May 2011

Themis Bioscience GmbH (www.themisbio.com), an Austrian start-up biotechnology company developing...

Themis Bioscience and Institut Pasteur form R&D alliance

Themis Bioscience and Institut Pasteur form R&D alliance

APEPTICO completes €3 million financing round

APEPTICO completes €3 million financing round

'Switch off, light on': molecular biologist discovers new control mechanism in cell signalling

Manuela Baccarini of the Centre for Molecular Biology of the University of Vienna (Max F. Perutz Laboratories)...

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on then-current expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? Just send your contributions to news(at)lisavienna.at.